New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense.

RATIONALE Host antioxidant defense, consisting of enzymatic antioxidant activity and nonenzymatic antioxidant micronutrients, is implicated in asthma pathogenesis. Studies of antioxidant defense and adult incident asthma have either used measures of antioxidants estimated from questionnaires or not considered enzymatic aspects of host defense. OBJECTIVES We conducted the first study designed and powered to investigate the association of antioxidant defenses on adult incident asthma. METHODS In a nested case-control study, we followed Shanghai women (aged 40-70 years) without prevalent asthma at baseline, over 8 years. Subjects with incident asthma were ascertained prospectively by gold standard testing of symptomatic women and matched to two asymptomatic control subjects. MEASUREMENTS AND MAIN RESULTS Baseline urinary F2-isoprostanes, plasma concentrations of antioxidant micronutrients (tocopherols, xanthines, carotenes, and lycopene), and antioxidant enzyme activity (platelet-activating factor acetylhydrolase [PAF-AH] and superoxide dismutase) were measured from samples collected before disease onset. Among 65,372 women, 150 (0.24%) developed asthma. F2-isoprostane levels before asthma onset were not different between cases and control subjects. Doubling of α-tocopherol concentrations and PAF-AH activity was associated with 50 and 37% decreased risk of incident asthma (α-tocopherol: adjusted odds ratio = 0.52; 95% confidence interval, 0.32-0.84; PAF-AH: adjusted odds ratio = 0.63; 95% confidence interval, 0.42-0.93). CONCLUSIONS In this prospective study, α-tocopherol, within normal reference ranges, and PAF-AH enzymatic activity were associated with decreased asthma development. These modifiable risk factors may be an effective strategy to test for primary asthma prevention.

[1]  A. Hyvärinen,et al.  Serum vitamin E concentrations at 1 year and risk of atopy, atopic dermatitis, wheezing, and asthma in childhood: the PASTURE study , 2014, Allergy.

[2]  T. Hartert,et al.  Two faces of vitamin E in the lung. , 2013, American journal of respiratory and critical care medicine.

[3]  M. Kiray,et al.  The Effect of Rupatadine on Lung Histopathology in a Murine Model of Chronic Asthma , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

[4]  Q. Husain,et al.  Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma , 2012, Annals of thoracic medicine.

[5]  L. Wood,et al.  Manipulating antioxidant intake in asthma: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[6]  Leena Choi,et al.  Natural‐source d‐α‐tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo , 2012, Allergy.

[7]  E. Fabian,et al.  Activities of Antioxidant Enzymes in Relation to Oxidative and Nitrosative Challenges in Childhood Asthma , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[8]  H. Abdala-Valencia,et al.  Supplemental and Highly Elevated Tocopherol Doses Differentially Regulate Allergic Inflammation: Reversibility of α-Tocopherol and γ-Tocopherol’s Effects , 2011, The Journal of Immunology.

[9]  D. Papakosta,et al.  Alterations of erythrocyte superoxide dismutase activity in patients suffering from asthma attacks. , 2010, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[10]  H. Abdala-Valencia,et al.  Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment (The Journal of Immunology (2009) 182, (4395-4405)) , 2010 .

[11]  L. Wood,et al.  Reduced circulating antioxidant defences are associated with airway hyper-responsiveness, poor control and severe disease pattern in asthma. , 2010, The British journal of nutrition.

[12]  F. Raffi,et al.  Evaluation of the tuberculin skin test and the interferon-γ release assay for TB screening in French healthcare workers , 2009, Journal of occupational medicine and toxicology.

[13]  J. Leonardi-Bee,et al.  Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis , 2009, Thorax.

[14]  E. Israel,et al.  Noninvasive Markers of Airway Inflammation in Asthma , 2009, Clinical and translational science.

[15]  F. Clavel-Chapelon,et al.  Dietary patterns and asthma in the E3N study , 2009, European Respiratory Journal.

[16]  O. Kalayci,et al.  A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. , 2008, The Journal of allergy and clinical immunology.

[17]  X. Shu,et al.  The Shanghai Women's Asthma and Allergy Study: objectives, design, and recruitment results. , 2008, American Journal of Epidemiology.

[18]  A. Nel,et al.  Importance of oxidative stress in the pathogenesis and treatment of asthma , 2008, Current opinion in allergy and clinical immunology.

[19]  L. Wood,et al.  Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: Proof of concept , 2008, Free radical research.

[20]  T. Bucciarelli,et al.  Plasma Lycopene and Antioxidant Vitamins in Asthma: the PLAVA Study , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[21]  K. Karasawa Clinical aspects of plasma platelet-activating factor-acetylhydrolase. , 2006, Biochimica et biophysica acta.

[22]  A. Mokdad,et al.  Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. , 2006, The American journal of clinical nutrition.

[23]  A. Mokdad,et al.  Distribution of serum concentrations of α-tocopherol and γ-tocopherol in the US population , 2006 .

[24]  H. Schünemann,et al.  Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD , 2006, European Journal of Clinical Nutrition.

[25]  C. Cunningham,et al.  Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. , 2006, Analytical biochemistry.

[26]  L. Wood,et al.  Airway and Circulating Levels of Carotenoids in Asthma and Healthy Controls , 2005, Journal of the American College of Nutrition.

[27]  N. Rothman,et al.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.

[28]  W. Busse,et al.  Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. , 2005, American journal of respiratory and critical care medicine.

[29]  A. Seaton,et al.  Diet as a risk factor for atopy and asthma. , 2005, The Journal of allergy and clinical immunology.

[30]  M. Chan-yeung,et al.  Systemic oxidative and antioxidative status in Chinese patients with asthma. , 2004, The Journal of allergy and clinical immunology.

[31]  R. Bowler Oxidative stress in the pathogenesis of asthma , 2004, Current allergy and asthma reports.

[32]  P. Cassano,et al.  Relationship of serum antioxidants to asthma prevalence in youth. , 2004, American journal of respiratory and critical care medicine.

[33]  D. Mannino,et al.  Serum Antioxidant Concentrations Among U.S. Adults with Self‐Reported Asthma , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[34]  C. Abnet,et al.  Prospective study of serum vitamin E levels and esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.

[35]  P. Gibson,et al.  Biomarkers of lipid peroxidation, airway inflammation and asthma , 2003, European Respiratory Journal.

[36]  T. Arinami,et al.  Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma , 2002, Journal of Human Genetics.

[37]  J. Morrow,et al.  Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2‐isoprostane, 15‐F2t‐IsoP (8‐iso‐PGF2α) , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[38]  P. Barnes,et al.  Elevation of exhaled ethane concentration in asthma. , 2000, American journal of respiratory and critical care medicine.

[39]  L. Wood,et al.  Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma , 2000, Lipids.

[40]  K. Deichmann,et al.  The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. , 2000, American journal of human genetics.

[41]  M. Tockman,et al.  Serum tocopherols, selenium and lung cancer risk among tin miners in China , 2000, Cancer Causes & Control.

[42]  J. Barberà,et al.  Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study. , 1999, The European respiratory journal.

[43]  T. Fukuda,et al.  Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. , 1999, The Journal of clinical investigation.

[44]  K. Enzan,et al.  PLATELET‐ACTIVATING FACTOR IS A KEY MEDIATOR OF PULMONARY VASOCONSTRICTION AND BRONCHOCONSTRICTION AFTER ANTIGEN CHALLENGE IN THE PERFUSED SENSITIZED RABBIT LUNG , 1998, Shock.

[45]  V. Peinado,et al.  Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. , 1998, The European respiratory journal.

[46]  R. Elswick,et al.  Interpretation of the odds ratio from logistic regression after a transformation of the covariate vector. , 1997, Statistics in medicine.

[47]  P. Barnes,et al.  Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. , 1997, American journal of respiratory and critical care medicine.

[48]  R. Louis,et al.  Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. , 1996, The European respiratory journal.

[49]  M. Yamakido,et al.  Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. , 1995, American journal of respiratory and critical care medicine.

[50]  F. Speizer,et al.  A prospective study of diet and adult-onset asthma. , 1995, American journal of respiratory and critical care medicine.

[51]  K. Chung,et al.  Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. , 1995, American journal of respiratory and critical care medicine.

[52]  P. Calverley,et al.  The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. , 1994, American journal of respiratory and critical care medicine.

[53]  P. O'Byrne,et al.  Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. , 1993, Thorax.

[54]  T. Takishima,et al.  Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs. , 1992, Journal of lipid mediators.

[55]  K. Hsieh Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children. , 1991, Chest.

[56]  H. Heuer,et al.  Inhibitory effects of the new PAF acether antagonist WEB‐2086 on pharmacologic changes induced by PAF inhalation in human beings , 1990, Clinical pharmacology and therapeutics.

[57]  K. Chung,et al.  Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings. , 1989, Allergy proceedings : the official journal of regional and state allergy societies.

[58]  M. A. Bray,et al.  Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. , 1987, European journal of pharmacology.

[59]  F. Cuss,et al.  EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MAN , 1986, The Lancet.

[60]  J. C. Smith,et al.  Determination of Individual Carotenoids in Human Plasma by High Performance Liquid Chromatography , 1985 .

[61]  S. Pilz,et al.  The challenge of setting appropriate intake recommendations for vitamin E: considerations on status and functionality to define nutrient requirements. , 2013, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[62]  S. Hazen,et al.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. , 2005, The American journal of pathology.

[63]  K. Asano,et al.  Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. , 1999, American journal of respiratory and critical care medicine.

[64]  L. Smith,et al.  Reduced superoxide dismutase in lung cells of patients with asthma. , 1997, Free radical biology & medicine.

[65]  T. Miyamoto,et al.  Effect of a potent platelet-activating factor antagonist, WEB-2086, on asthma. A multicenter, double-blind placebo-controlled study in Japan. , 1996, Advances in experimental medicine and biology.

[66]  K. P. Hui,et al.  Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen. , 1993, The American review of respiratory disease.

[67]  D. Stafforini,et al.  Platelet-activating factor acetylhydrolase from human plasma. , 1990, Methods in enzymology.

[68]  J. C. Smith,et al.  Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. , 1988, Clinical chemistry.